Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/10/2003WO2002074238A3 Water soluble and palatable complexes
04/10/2003WO2002071827A3 Retinoid x receptor modulators
04/10/2003WO2002070540A3 Peptide deformylase inhibitors
04/10/2003WO2002070070A3 Compositions having improved bioavailability of eletriptan
04/10/2003WO2002065988A3 Terminally-branched polymeric linkers and polymeric conjugates containing the same
04/10/2003WO2002060423A3 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
04/10/2003WO2002060412A3 Stabilised polymeric aerosols for pulmonary gene delivery
04/10/2003WO2002059083A3 Novel compounds
04/10/2003WO2002055688A3 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
04/10/2003WO2002055095A8 Use of aziridino-compounds in the treatment of immune dysfunctions
04/10/2003WO2002053169A8 Use of dipeptylpeptidase iv and aminopeptidase-n inhibitors in the treatment of ischaemia-induced neuro-degeneration
04/10/2003WO2002053104A3 Use of catecholamine reuptake inhibitors to enhance memory
04/10/2003WO2002049629A3 Methods for reducing chronic stress in mammals
04/10/2003WO2002045687A3 Topical alcoholic solution of a salicylic acid derivative and acemannan
04/10/2003WO2002041889A3 Indolsulfonyl compounds useful in the treatment of cns disorders
04/10/2003WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same
04/10/2003WO2002036175A3 Sustained release device for treating conditions of the joint
04/10/2003WO2002036135A3 Compositions for antitumour treatment containing ecteinascidin 743
04/10/2003WO2002034241A3 Compounds comprising a phytosterol and/or phytostanol moiety and ascorbis acid and use thereof as weight regulating agents
04/10/2003WO2002017896A3 Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
04/10/2003WO2002009678A3 Charged phospholipid compositions and methods for their use
04/10/2003WO2002000174A3 Compositions and methods for the therapy and diagnosis of lung cancer
04/10/2003WO2001087295A8 Methods for decreasing cell proliferation based on (3r, 4r)-δ8-tetrahydrocannabinol-11-oic acids
04/10/2003US20030069618 Method, kit and device for the treatment of cosmetic skin conditions
04/10/2003US20030069535 Stabilized polyester/cyanoacrylate tissue adhesive formulation
04/10/2003US20030069435 Prevention of neutrophil recruitment
04/10/2003US20030069434 Antiestrogenic properties or tissue-selective estrogenic properties
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069429 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
04/10/2003US20030069428 Pharmaceutically active isoindoline derivatives
04/10/2003US20030069425 Substituted pyrimidine compounds and methods of use
04/10/2003US20030069423 Novel processes for the preparation of adenosine compounds and intermediates thereto
04/10/2003US20030069422 Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
04/10/2003US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group
04/10/2003US20030069416 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
04/10/2003US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
04/10/2003US20030069396 Neutralizing agent for toxin of microorganism belonging to the genus clostridium
04/10/2003US20030069393 Compound for use in the treatment of cancer and prevention of infections
04/10/2003US20030069318 Salts of analgesic substances in oil, and methods of making and using the same
04/10/2003US20030069316 Use of comt inhibitors as analgesics
04/10/2003US20030069315 New use for 1,3-propanediol derivatives
04/10/2003US20030069314 Therapy for incotinence
04/10/2003US20030069313 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
04/10/2003US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them
04/10/2003US20030069311 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
04/10/2003US20030069310 Salicylic acid salts of salmeterol
04/10/2003US20030069309 Antiinflammatory agents; analgesics; antipyretics
04/10/2003US20030069308 Antidiabetic agents
04/10/2003US20030069306 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
04/10/2003US20030069304 Antidepressants
04/10/2003US20030069303 Osteoporosis, postmenopause
04/10/2003US20030069302 Hydrophilic and lipophilic silibinin pro-forms
04/10/2003US20030069301 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
04/10/2003US20030069300 Huntington disease; schizophrenia
04/10/2003US20030069298 Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
04/10/2003US20030069297 4-aryl substituted indolinones
04/10/2003US20030069296 Central nervous system disorders
04/10/2003US20030069295 Using imidazole compound; weight reduction
04/10/2003US20030069294 Alpha-substituted carboxylic acid derivatives
04/10/2003US20030069293 Medicament
04/10/2003US20030069292 Central nervous system disorders; anticonvulsants
04/10/2003US20030069290 Substituted-heteroaryl-7-aza[2.2.1] bycycloheptanes for the treatment of desease
04/10/2003US20030069289 Alzheimer*s disease
04/10/2003US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives
04/10/2003US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
04/10/2003US20030069286 Vision defects
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069283 Administering insulin sensitizer
04/10/2003US20030069282 Cardiovascular disorders; antidiabetic agents; insulin sensitizer
04/10/2003US20030069280 S(-)rabeprazole compositions and methods
04/10/2003US20030069279 Antimicrobial agent
04/10/2003US20030069278 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
04/10/2003US20030069277 Anticancer agents
04/10/2003US20030069276 Viricides; aids therapy
04/10/2003US20030069274 Pharmaceutically active compounds and methods of use
04/10/2003US20030069273 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
04/10/2003US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid
04/10/2003US20030069271 Quinolone compounds for use in treating viral infections
04/10/2003US20030069270 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxImic acid derivative
04/10/2003US20030069266 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/10/2003US20030069265 Multiple sclerosis; rheumatic diseases; skin disorders
04/10/2003US20030069264 Method of determining and reducing the risk of bph-related urologic events
04/10/2003US20030069263 Prevention drug abruse; analgesics
04/10/2003US20030069262 Neutral antagonists and use thereof in treating drug abuse
04/10/2003US20030069260 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
04/10/2003US20030069257 Benzimidazole and pyridylimidazole derivatives
04/10/2003US20030069256 Use of isogenic human cancer cells for high-throughput screening and drug discovery
04/10/2003US20030069255 Pharmaceutical compositions for the coordinated delivery of NSAIDs
04/10/2003US20030069254 New arylsulfonyl derivatives with 5-HT6 receptor affinity
04/10/2003US20030069253 Compositions and methods for treating otic, ophthalmic and nasal infections
04/10/2003US20030069252 Viricides; antiinflammatory agents
04/10/2003US20030069251 Antianxiety composition
04/10/2003US20030069249 Analgesics; central nervous system disorders
04/10/2003US20030069248 Antiinflammatory agents; controlling cell cycle
04/10/2003US20030069246 Central nervous system disorders; psychological disorders; cardiovascular disorders
04/10/2003US20030069245 Aids therapy
04/10/2003US20030069243 Novel substituted imidazole compounds
04/10/2003US20030069242 3-arylphenyl sulfide derivative and insecticide and miticide
04/10/2003US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
04/10/2003US20030069239 Anticancer agents
1 ... 5505 5506 5507 5508 5509 5510 5511 5512 5513 5514 5515 5516 5517 5518 5519 5520 5521 5522 5523 5524 5525 ... 7860